Literature DB >> 10567525

Mycoplasmal infections prevent apoptosis and induce malignant transformation of interleukin-3-dependent 32D hematopoietic cells.

S H Feng1, S Tsai, J Rodriguez, S C Lo.   

Abstract

32D cells, a murine myeloid cell line, rapidly undergo apoptosis upon withdrawal of interleukin-3 (IL-3) supplement in culture. We found that 32D cells, if infected by several species of human mycoplasmas that rapidly activated NF-kappaB, would live and continue to grow in IL-3-depleted culture. Mycoplasma-infected cells showed no evidence of autocrine production of IL-3. Pyrrolidine dithiocarbamate (PDTC) blocked activation of NF-kappaB and led to prominent cell death. Heat-killed mycoplasmas or mycoplasmal membrane preparations alone could support continued growth of 32D cells in culture without IL-3 supplement for a substantial period of time. However, upon removal of heat-inactivated mycoplasmas, 32D cells quickly became apoptotic. In comparison, live Mycoplasma fermentans or M. penetrans infection for 4 to 5 weeks induced malignant transformation of 32D cells. Transformed 32D cells grew autonomously and no longer required support of growth-stimulating factors including IL-3 and mycoplasmas. The transformed 32D cells quickly formed tumors when injected into nude mice. Karyotyping showed that development of chromosomal changes and trisomy 19 was often associated with malignant transformation and tumorigenicity of 32D cells. Mycoplasmal infections apparently affected the fidelity of genomic transmission in cell division as well as checkpoints coordinating the progression of cell cycle events.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10567525      PMCID: PMC84884          DOI: 10.1128/MCB.19.12.7995

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  33 in total

1.  POSSIBLE ASSOCIATION BETWEEN LEUKEMIA IN CHILDREN AND VIRUS-LIKE AGENTS.

Authors:  W H MURPHY; D FURTADO; E PLATA
Journal:  JAMA       Date:  1965-01-11       Impact factor: 56.272

2.  DIRECT AGAR ISOLATION OF MYCOPLASMAS FROM HUMAN LEUKAEMIC BONE MARROW.

Authors:  L HAYFLICK; H KOPROWSKI
Journal:  Nature       Date:  1965-02-13       Impact factor: 49.962

3.  Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells.

Authors:  E Schreiber; P Matthias; M M Müller; W Schaffner
Journal:  Nucleic Acids Res       Date:  1989-08-11       Impact factor: 16.971

4.  Mouse chromosomes identified by trypsin-Giemsa (T-G) banding.

Authors:  D H Wurster
Journal:  Cytogenetics       Date:  1972

5.  Isolation of mycoplasma from leukemic and nonleukemic patients.

Authors:  W H Murphy; C Bullis; L Dabich; R Heyn; C J Zarafonetis
Journal:  J Natl Cancer Inst       Date:  1970-08       Impact factor: 13.506

6.  Mycoplasmas (PPLO) and human leukemia and lymphoma.

Authors:  J T Grace; J S Horoszewicz; T B Stim; E A Mirand; C James
Journal:  Cancer       Date:  1965-10       Impact factor: 6.860

7.  Mycoplasma studies of human leukemia.

Authors:  W H Murphy; C Bullis; I J Ertel; C J Zarafonetis
Journal:  Ann N Y Acad Sci       Date:  1967-07-28       Impact factor: 5.691

8.  Chromosome changes in human diploid-cell cultures infected with Mycoplasma.

Authors:  G R Paton; J P Jacobs; F T Perkins
Journal:  Nature       Date:  1965-07-03       Impact factor: 49.962

9.  Demonstration of permanent factor-dependent multipotential (erythroid/neutrophil/basophil) hematopoietic progenitor cell lines.

Authors:  J S Greenberger; M A Sakakeeny; R K Humphries; C J Eaves; R J Eckner
Journal:  Proc Natl Acad Sci U S A       Date:  1983-05       Impact factor: 11.205

10.  Interleukin 3-dependent hematopoietic progenitor cell lines.

Authors:  J S Greenberger; R J Eckner; M Sakakeeny; P Marks; D Reid; G Nabel; A Hapel; J N Ihle; K C Humphries
Journal:  Fed Proc       Date:  1983-07
View more
  41 in total

1.  Identification of antigens by monoclonal antibody PD4 and its expression in Escherichia coli.

Authors:  Jin-Ying Ning; Guo-Xun Sun; Su Huang; Hong Ma; Ping An; Lin Meng; Shu-Mei Song; Jian Wu; Cheng-Chao Shou
Journal:  World J Gastroenterol       Date:  2003-10       Impact factor: 5.742

2.  Mycoplasma hyorhinis reduces sensitivity of human lung carcinoma cells to Nutlin-3 and promotes their malignant phenotype.

Authors:  Uljana A Boyarskikh; Alexandra S Shadrina; Mariya A Smetanina; Yakov A Tsepilov; Igor P Oscorbin; Vadim V Kozlov; Alexander E Kel; Maxim L Filipenko
Journal:  J Cancer Res Clin Oncol       Date:  2018-05-08       Impact factor: 4.553

Review 3.  Interactions between mycoplasma lipid-associated membrane proteins and the host cells.

Authors:  Xiao-xing You; Yan-hua Zeng; Yi-mou Wu
Journal:  J Zhejiang Univ Sci B       Date:  2006-05       Impact factor: 3.066

4.  Mycoplasma infections and different human carcinomas.

Authors:  S Huang; J Y Li; J Wu; L Meng; C C Shou
Journal:  World J Gastroenterol       Date:  2001-04       Impact factor: 5.742

5.  Computational prediction of Mycoplasma hominis proteins targeting in nucleus of host cell and their implication in prostate cancer etiology.

Authors:  Shahanavaj Khan; Mohammed Zakariah; Sellappan Palaniappan
Journal:  Tumour Biol       Date:  2016-02-13

6.  Structural insights into the extracytoplasmic thiamine-binding lipoprotein p37 of Mycoplasma hyorhinis.

Authors:  Katherine H Sippel; Arthur H Robbins; Robbie Reutzel; Susan K Boehlein; Kazunori Namiki; Steve Goodison; Mavis Agbandje-McKenna; Charles J Rosser; Robert McKenna
Journal:  J Bacteriol       Date:  2009-02-20       Impact factor: 3.490

7.  Mycoplasma hyorhinis infection in gastric carcinoma and its effects on the malignant phenotypes of gastric cancer cells.

Authors:  Hua Yang; Like Qu; Huachong Ma; Ling Chen; Wenbin Liu; Caiyun Liu; Lin Meng; Jian Wu; Chengchao Shou
Journal:  BMC Gastroenterol       Date:  2010-11-10       Impact factor: 3.067

8.  Effect of mycoplasmas on apoptosis of 32D cells is species-dependent.

Authors:  Shimin Zhang; Shyh-Ching Lo
Journal:  Curr Microbiol       Date:  2007-05-05       Impact factor: 2.188

9.  Mycoplasma infection suppresses p53, activates NF-kappaB and cooperates with oncogenic Ras in rodent fibroblast transformation.

Authors:  D Y Logunov; D V Scheblyakov; O V Zubkova; M M Shmarov; I V Rakovskaya; K V Gurova; N D Tararova; L G Burdelya; B S Naroditsky; A L Ginzburg; A V Gudkov
Journal:  Oncogene       Date:  2008-04-14       Impact factor: 9.867

10.  Persistent exposure to Mycoplasma induces malignant transformation of human prostate cells.

Authors:  Kazunori Namiki; Steve Goodison; Stacy Porvasnik; Robert W Allan; Kenneth A Iczkowski; Cydney Urbanek; Leticia Reyes; Noboru Sakamoto; Charles J Rosser
Journal:  PLoS One       Date:  2009-09-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.